West Paces Advisors’s Nutanix NTNX Stock Holding History

West Paces Advisors’s Portfolio NTNX Stock Details NTNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7	Closed	-$146	–	547
2022 Q3	$146	Sell	7 -7	-50%	-$128	﹤0.01%	516
2022 Q2	$205	Hold	14	–	–	﹤0.01%	572
2022 Q1	$375	Hold	14	–	–	﹤0.01%	559
2021 Q4	$446	Buy	14 +4	+40%	+$137	﹤0.01%	561
2021 Q3	$377	Buy	+10	New	+$378	﹤0.01%	566

Other funds holding NTNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

PCM

Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

West Paces Advisors's NTNX Position: Q4 2022 in Review

West Paces Advisors sold out of Nutanix (NTNX) in Q4 2022, closing a stake of 7 shares — an estimated $146 sold.

West Paces Advisors first reported a position in NTNX in Q3 2021 and held it in 5 quarters. The position peaked at $446 in Q4 2021. 321 funds tracked by Wall St. Rank hold NTNX as of Q4 2022.

West Paces Advisors reported no remaining Nutanix position as of Q4 2022 after selling out during the quarter.
West Paces Advisors sold 7 Nutanix shares in Q4 2022, an estimated $146.
West Paces Advisors first reported a position in Nutanix in Q3 2021 and held it in 5 quarters.
West Paces Advisors's Nutanix position peaked at $446 in Q4 2021.
321 funds tracked by Wall St. Rank held Nutanix as of Q4 2022.

Based on West Paces Advisors's 13F filing for Q4 2022, filed 18 Dec 2023.